Single-centre experience of an early cannulation graft for haemodialysis access.

Szczegóły
Abstrakt

Tytuł:: Single-centre experience of an early cannulation graft for haemodialysis access.
Autorzy:: Sutaria R; Wessex Kidney Centre, Queen Alexandra Hospital, Portsmouth, UK.
Gilbert JA; Oxford Transplant Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
Źródło:: The journal of vascular access [J Vasc Access] 2020 Nov; Vol. 21 (6), pp. 883-891. Date of Electronic Publication: 2020 Mar 06.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: 2018- : Thousand Oaks, CA : Sage Publications
Original Publication: Milano ; Birmingham : Wichtig, c2000-
MeSH Terms:: Blood Vessel Prosthesis*/adverse effects
Catheterization*/adverse effects
Renal Dialysis*
Time-to-Treatment*
Arteriovenous Shunt, Surgical/*instrumentation
Blood Vessel Prosthesis Implantation/*instrumentation
Adult ; Aged ; Aged, 80 and over ; Arteriovenous Shunt, Surgical/adverse effects ; Blood Vessel Prosthesis Implantation/adverse effects ; Female ; Graft Occlusion, Vascular/etiology ; Graft Occlusion, Vascular/physiopathology ; Humans ; Male ; Middle Aged ; Prosthesis Design ; Prosthesis-Related Infections/microbiology ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Vascular Patency
Contributed Indexing:: Keywords: Dialysis access; Flixene; arteriovenous access; early cannulation graft; prosthetic grafts
Entry Date(s):: Date Created: 20200307 Date Completed: 20201123 Latest Revision: 20220418
Update Code:: 20240105
DOI:: 10.1177/1129729820909026
PMID:: 32141378
: Czasopismo naukowe

Introduction: As the demographics of the population changes, increasing challenges are being faced in providing reliable access for dialysis. This article reports on the outcomes from the largest series to date using the early cannulation graft Flixene in a single centre.
Methods: Between May 2012 and March 2018, 141 Flixene grafts were placed for dialysis access. The outcomes of the arteriovenous grafts were reviewed retrospectively from electronically held records and imaging.
Results: In 75 patients, placement of Flixene graft was performed on an emergency basis and in 66 patients on a planned elective list. The 12-month primary, assisted primary and secondary patency rates were 48.7%, 56.6% and 83.6%, respectively. Eight (5.7%) patients developed infections of the graft during the follow-up period.
Conclusion: In our experience, we have found the use of the early cannulation graft Flixene to be safe with a low complication rate and favourable patency rates. We believe these early cannulation grafts provide a useful addition for vascular access surgeons preventing the use of tunnelled lines and providing more flexibility in the timing of placing a graft for dialysis.

Informacja